The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.
The Nemours HTS & Drug Discovery Lab is one of only a few such facilities worldwide dedicated exclusively to technology development and drug discovery for rare childhood diseases underserved by current pharmaceutical development efforts. Projects...View all
Johnson & Johnson and Institute for Molecular Bioscience (IMB) at University of Queensland have entered into research agreement to develop peptides using IMB's novel assay to treat chronic pain. Johnson & Johnson and its affiliates will provide fu...View all
Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges
09 December, 2014
Circulating Biomarkers World Congress
23 March, 2015
Overview: PUSHING BEYOND www.dekalbmedical.org www.dekalbmedic...
28 June, 2013
Sr. Clinical Research Associate - Medical Devices (900)
We’ve been engaged by our client to recruit their Sr. Clinical ...
24 June, 2013